Skin Cancer

Facing a Skin Cancer Diagnosis With Clarity and Confidence

Hearing the words “skin cancer” can create immediate concern, even when the cancer has been found early. Many patients worry about whether the cancer has spread, whether surgery will change their appearance, whether they will need radiotherapy or drug treatment, and how quickly they should make decisions. For international patients, these questions are often accompanied by practical concerns: where to receive care, how to obtain an accurate diagnosis, and how to coordinate treatment far from home.

Skin cancer is not one disease. It includes several cancers with different behaviors, risks and treatment pathways. Some grow slowly and are highly treatable with a precise surgical procedure. Others, especially melanoma and certain high-risk squamous cell carcinomas, require careful staging and coordinated care from several specialists. The most important first step is understanding exactly what type of skin cancer you have, how deep or advanced it is, and which treatment plan offers the best balance between cancer control, safety, function and cosmetic outcome.

At Acibadem, skin cancer care is organized around accurate diagnosis, individualized treatment planning and multidisciplinary decision-making when needed. Dermatology, plastic and reconstructive surgery, surgical oncology, medical oncology, radiation oncology, pathology, radiology and nuclear medicine specialists may all be involved depending on the diagnosis. For patients traveling from abroad, Acibadem International helps coordinate medical records, appointments, interpretation and hospital logistics so that care can begin with a clear plan.

What Skin Cancer Care Includes

Skin cancer care includes the full pathway from evaluation of a suspicious mole, spot or lesion to diagnosis, staging, treatment and follow-up. The goal is to remove or control the cancer while preserving healthy tissue, appearance and quality of life as much as possible. Treatment may be straightforward for a small basal cell carcinoma or more complex for melanoma, recurrent tumors, cancers on the face, or tumors that have spread to lymph nodes or other organs.

The main types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma. Basal cell carcinoma is the most common form and usually grows slowly, but it can damage surrounding tissues if neglected. Squamous cell carcinoma can behave more aggressively, especially when it is large, deep, recurrent, located on high-risk areas or occurs in patients with weakened immune systems. Melanoma is less common than basal and squamous cell cancers but has a greater tendency to spread if not diagnosed and treated early.

Treatment may involve one or more approaches. Surgery is often the central treatment for localized skin cancer. This may include excision with appropriate margins, specialized margin-controlled techniques, lymph node procedures or reconstructive surgery. Radiotherapy can be used when surgery is not suitable, after surgery in selected high-risk cases, or for symptom control in advanced disease. Systemic therapy, including immunotherapy, targeted therapy or chemotherapy in selected situations, may be recommended for melanoma or advanced non-melanoma skin cancers. The right plan depends on tumor type, stage, location, molecular features, prior treatments and the patient’s overall health.

Who May Need Skin Cancer Evaluation and Treatment

Skin cancer can appear in many ways. Some lesions are obvious, while others are subtle and easy to overlook. A new spot that does not heal, a changing mole, a bleeding bump, a rough scaly patch, a dark streak under a nail, or a sore on the lip or ear should be assessed by a qualified physician. The evaluation is especially important if the lesion is changing in size, color, shape or texture, or if it becomes painful, itchy, crusted or ulcerated.

Patients who may need skin cancer care include those with a newly diagnosed biopsy result, those who have a suspicious lesion that has not yet been biopsied, and those seeking a second opinion after being advised to have surgery, radiotherapy or systemic therapy. Some patients come for treatment after a cancer has returned following previous removal. Others need a multidisciplinary review because the cancer is close to the eye, nose, mouth, ear, scalp, hand or genital area, where both cancer control and reconstruction require careful planning.

Diagnosis usually begins with a clinical examination of the skin and, when appropriate, dermoscopic assessment. Dermoscopy allows the physician to view patterns and structures not visible to the naked eye, helping distinguish benign lesions from suspicious ones. If cancer is suspected, a biopsy is performed. The biopsy method may be an excisional biopsy, punch biopsy, shave biopsy or incisional biopsy depending on the lesion and location. Pathology then confirms the diagnosis and provides key details such as cancer type, depth, ulceration, margins, nerve involvement and other risk features.

For melanoma and higher-risk cancers, additional staging may be needed. This can include imaging studies, sentinel lymph node biopsy, lymph node ultrasound or other tests depending on the clinical situation. In advanced melanoma and selected other cancers, molecular testing may help identify specific mutations that influence treatment choices. Accurate staging is essential because early-stage disease and advanced disease require very different strategies.

Conditions and Indications Addressed

Comprehensive skin cancer care addresses both common and complex skin malignancies. The treatment pathway is adapted to the tumor type, stage and patient priorities. Indications may include early treatment, recurrence management, staging, reconstruction, or coordination of drug therapy and radiotherapy.

• Basal cell carcinoma: including superficial, nodular, infiltrative or recurrent tumors, especially in cosmetically or functionally sensitive areas.
• Squamous cell carcinoma: including low-risk lesions, high-risk tumors, recurrent disease and cancers with nerve involvement or lymph node spread.
• Melanoma: from early thin melanoma to thicker tumors, nodal disease or metastatic melanoma requiring systemic therapy.
• Merkel cell carcinoma: a less common but aggressive skin cancer that often requires multidisciplinary treatment.
• Skin cancers in high-risk locations: including the eyelids, nose, lips, ears, scalp, hands, feet and genital area.
• Recurrent skin cancer: cancers returning after prior surgery, radiotherapy or other treatment.
• Skin cancers in immunosuppressed patients: including transplant recipients and patients receiving long-term immune-suppressing medication.
• Advanced or metastatic skin cancer: disease that has spread to lymph nodes, soft tissue, bone, lung, liver, brain or other organs.

Not every patient needs every treatment modality. A small, low-risk basal cell carcinoma may be managed with a localized procedure, while melanoma may require a wider excision, nodal evaluation and oncology review. The value of a coordinated program is that each patient’s plan is based on the biology of the cancer rather than a single standard approach.

How Skin Cancer Treatment Is Performed

Preparation and Treatment Planning

The process begins with a detailed medical review. Patients are usually asked to provide pathology reports, biopsy slides or blocks if available, prior operation notes, imaging studies, photographs of the lesion, medication lists and relevant medical history. For international patients, these documents can often be reviewed before travel so the appropriate specialists can be identified and appointments planned efficiently.

During the initial consultation, the physician examines the lesion and surrounding skin, checks regional lymph nodes when relevant, and reviews the pathology. If the diagnosis is uncertain or the pathology needs confirmation, a second pathology review may be requested. In skin cancer, pathology is central to treatment planning. A few millimeters in depth, a positive margin, ulceration, perineural invasion or lymphovascular involvement can significantly change the recommended plan.

When staging is necessary, imaging may include ultrasound, computed tomography, magnetic resonance imaging, positron emission tomography combined with computed tomography, or brain imaging for selected melanoma patients. These technologies help identify whether disease is localized or has spread. For some patients with melanoma, sentinel lymph node biopsy is considered to evaluate microscopic lymph node involvement. In advanced melanoma, molecular testing may be used to determine whether targeted treatment options are relevant.

Surgery for Localized Skin Cancer

Surgery is the most common treatment for localized skin cancer. The procedure is planned according to tumor type, size, depth and location. For many basal cell and squamous cell carcinomas, the cancer is removed with a margin of surrounding healthy tissue to reduce the risk of leaving cancer cells behind. The specimen is sent to pathology to confirm the diagnosis and assess margins. If the cancer is on the face or another visible or delicate area, the surgical plan also considers the best method of closure or reconstruction.

Some patients need more specialized surgical approaches. Margin-controlled surgery may be considered for selected high-risk non-melanoma skin cancers, particularly when tissue preservation is important. For melanoma, wide local excision is performed with margins guided by tumor thickness and international protocols. When indicated, sentinel lymph node biopsy may be performed during the same surgical session or as a coordinated procedure. This helps determine whether melanoma has begun to spread through the lymphatic system.

Reconstruction can range from a simple layered closure to local flaps, skin grafts or more complex reconstructive techniques. The aim is not only to close the wound, but to preserve function and achieve the best reasonable cosmetic result. This is especially important for cancers near the eyelid, lip, nose, ear or hand, where small differences in tissue alignment can affect daily life.

Radiotherapy When Needed

Radiotherapy uses carefully planned radiation beams to damage cancer cells while limiting exposure to surrounding healthy tissues. It may be used as the primary treatment when surgery is not medically appropriate or when surgery would cause unacceptable functional or cosmetic effects. It may also be recommended after surgery for selected high-risk squamous cell carcinomas, cancers with nerve involvement, positive margins that cannot be further excised, or some nodal disease situations.

Before radiotherapy begins, the patient undergoes treatment simulation and planning. Imaging is used to define the treatment area, and the radiation oncology team calculates the dose and delivery pattern. Treatment is typically delivered over multiple sessions. The exact schedule depends on tumor type, location, treatment intent and the patient’s overall condition. Side effects may include skin redness, dryness, peeling, fatigue or localized discomfort; these are monitored and managed during treatment.

Systemic Therapy for Advanced or High-Risk Disease

Systemic therapy treats cancer throughout the body and is most commonly used for advanced melanoma, metastatic disease, unresectable tumors or selected high-risk situations. Immunotherapy can help the immune system recognize and attack cancer cells. Targeted therapy may be used for cancers with specific molecular changes, particularly certain melanomas. Chemotherapy is used less often for melanoma than in the past, but it may still have a role in selected skin cancers or treatment sequences.

Decisions about systemic therapy require careful evaluation of disease extent, molecular findings, autoimmune conditions, organ function, prior treatments and patient preferences. Treatment is monitored with clinical examinations, blood tests and imaging at appropriate intervals. Side effects vary by medication and may affect the skin, bowel, liver, lungs, endocrine system or other organs. Early recognition and management of side effects are important parts of safe cancer care.

Typical Duration and Immediate Recovery

The time required for skin cancer treatment varies widely. A small surgical excision may be performed as an outpatient procedure and take less than an hour, while complex surgery with reconstruction or lymph node procedures may take longer and require a short hospital stay. Radiotherapy typically involves repeated visits over days or weeks. Systemic therapy is delivered in cycles or scheduled intervals, and the overall course depends on the cancer type, response and tolerability.

After minor surgery, many patients return to light daily activities quickly, with wound care instructions and restrictions on strenuous exercise until healing is secure. Stitches may be removed after several days to two weeks depending on the area treated. More complex reconstruction requires closer follow-up and a more cautious recovery. Patients receiving radiotherapy or systemic treatment continue regular monitoring to evaluate both the cancer and treatment effects.

Why Acting Early Matters

Early skin cancer treatment generally allows for smaller procedures, simpler reconstruction and a greater chance of controlling the cancer before it spreads. Basal cell carcinoma rarely spreads to distant organs, but it can invade deeper tissues over time and become more difficult to remove. Squamous cell carcinoma can spread to lymph nodes or other sites, especially when high-risk features are present. Melanoma is particularly time-sensitive because the risk of spread increases as the tumor becomes thicker and more biologically aggressive.

Delaying evaluation may allow a lesion to grow larger, penetrate deeper layers of skin, involve nerves or cartilage, or reach lymphatic and blood vessels. This can change a patient’s treatment from a simple outpatient procedure to a more complex operation, radiotherapy or systemic therapy. Delay may also narrow reconstructive options, especially for cancers on the face, scalp, hands or feet.

Acting early does not mean rushing into treatment without understanding the diagnosis. It means obtaining a reliable pathology report, completing necessary staging, and moving forward with an evidence-based plan in a timely way. For patients considering care abroad, early communication and record review can help reduce unnecessary waiting and support a more organized treatment journey.

Potential Benefits of Skin Cancer Treatment

The benefits of treatment depend on the type and stage of cancer, but timely, well-planned care can provide several important advantages.

Benefit	What It Means for You
Local cancer control	Removing or treating the visible cancer and surrounding at-risk tissue can reduce the chance of continued growth in the treated area.
Lower risk of spread in appropriate cases	For melanoma and high-risk squamous cell carcinoma, accurate staging and timely treatment help identify and address disease before it advances further.
Preservation of function	Careful planning is especially important near the eyes, lips, nose, ears, fingers or joints, where treatment must protect daily activities as much as possible.
Improved cosmetic planning	When surgery is required, reconstructive techniques can help minimize visible changes while maintaining cancer safety.
Personalized treatment choices	Patients with advanced disease may benefit from therapy selected according to tumor type, stage, molecular findings and overall health.
Structured follow-up	Ongoing surveillance helps detect recurrence, new skin cancers or treatment-related issues at an earlier stage.

Recovery Timeline After Skin Cancer Treatment

Recovery varies according to the treatment performed, the size and location of the cancer, and the patient’s general health, but the following timeline reflects common expectations.

Time Period	What Patients Can Expect
Day 1	After minor surgery, patients usually go home the same day with dressing and wound care instructions. After more complex surgery, observation or hospital stay may be needed.
First Week	Swelling, bruising, tightness or mild discomfort may occur around the treated area. Patients are advised to protect the wound, avoid heavy activity and attend scheduled checks.
First Month	Most surgical wounds become stronger and more comfortable. Stitches may already have been removed, and pathology results are reviewed to confirm whether further treatment is needed.
During Radiotherapy or Systemic Therapy	Patients attend planned sessions or treatment cycles. The care team monitors skin reactions, fatigue, laboratory results and any immune-related or medication-related side effects.
Longer Term	Scars continue to mature for months. Follow-up visits focus on recurrence surveillance, skin checks, sun protection guidance and early detection of new lesions.

Factors That Influence Outcomes

Skin cancer outcomes are influenced by many factors, and no responsible physician can predict an individual result with certainty before a complete evaluation. However, several features are consistently important in treatment planning. The type of cancer is one of the strongest determinants. Basal cell carcinoma usually behaves differently from melanoma, and a superficial tumor differs from one that has invaded deeply or spread to nodes.

Stage at diagnosis is also essential. Tumors found when they are small and localized often require less extensive treatment. Melanoma thickness, ulceration, mitotic activity, lymph node involvement and distant spread are key prognostic details. For squamous cell carcinoma, tumor size, depth, location, perineural invasion, immune status and prior recurrence influence risk. Margin status after surgery helps determine whether the cancer has been fully removed or whether further treatment should be considered.

Location matters. A small cancer on the cheek may be easier to manage than a similar-sized tumor on the eyelid, nose, ear canal, lip or finger. Prior treatment can also affect outcomes because recurrent tumors may have scar tissue, altered anatomy or more aggressive behavior. A patient’s immune system, age, other medical conditions and medications may influence healing and treatment tolerance.

The quality of diagnosis and coordination of care can make a meaningful difference. Accurate pathology review, appropriate imaging, thoughtful surgical margins, careful reconstruction and timely oncology input all help align treatment with the actual risk of disease. For advanced melanoma and selected other cancers, access to immunotherapy, targeted therapy, molecular testing and experienced side-effect management can be important components of care.

Patient participation is another important factor. Following wound care instructions, attending follow-up visits, reporting new symptoms, protecting skin from ultraviolet exposure and performing regular self-examinations all support long-term surveillance. Skin cancer patients have an increased risk of developing additional skin cancers, so follow-up is not only about the treated lesion; it is also about monitoring the skin as a whole.

Why International Patients Choose Acibadem for Skin Cancer Care

International patients considering skin cancer treatment abroad often seek more than a procedure. They need a reliable diagnosis, a clear treatment sequence, experienced physicians, coordinated scheduling and communication in a language they understand. At Acibadem, care is delivered within JCI-accredited hospitals and supported by a dedicated international patient services structure designed for patients traveling from outside Turkey.

The medical pathway is shaped by the complexity of the case. A patient with a straightforward basal cell carcinoma may be managed by dermatology and surgical specialists with pathology confirmation. A patient with melanoma, high-risk squamous cell carcinoma, recurrent disease or metastatic cancer may be discussed by a multidisciplinary tumor board or specialist board. These meetings bring together relevant physicians to review pathology, imaging, surgical options, radiation indications and systemic therapy choices. This approach supports treatment plans based on international and evidence-based protocols while still adapting to the individual patient.

Advanced diagnostic and treatment technologies play an important role, but they are used as tools within a broader clinical strategy. Dermoscopic evaluation helps identify suspicious lesions. High-quality pathology supports precise classification and risk assessment. Cross-sectional and functional imaging can help stage advanced disease. Modern radiotherapy planning helps focus treatment on the intended area while limiting exposure to nearby tissues. In operating rooms, microsurgical and reconstructive techniques may support repair after tumor removal in delicate locations. In oncology units, systemic treatments are administered with careful monitoring and structured management of side effects.

Acibadem’s experience across dermatology, plastic and reconstructive surgery, surgical oncology, medical oncology, radiation oncology, radiology, nuclear medicine and pathology allows patients to move between specialties when their condition requires it. This is particularly valuable when treatment decisions are not obvious, such as whether a melanoma patient needs sentinel lymph node biopsy, whether a high-risk squamous cell carcinoma should receive postoperative radiotherapy, or whether advanced melanoma should begin with immunotherapy or targeted therapy.

For patients coming from the United States or other countries, the international patient team can assist with appointment planning, medical record transfer, translation and interpretation, airport and accommodation coordination when requested, and communication with the clinical team. Services are available in more than 20 languages, helping patients and families understand medical recommendations, consent processes, medication instructions and follow-up plans.

Personalized treatment planning is central to skin cancer care because the best option is not always the most extensive option. For some patients, the safest plan is a focused outpatient procedure. For others, it may involve surgery followed by radiotherapy, or systemic therapy with ongoing imaging. The aim is to recommend care that is medically appropriate, technically sound and respectful of the patient’s priorities, including travel timing, recovery needs, appearance, work responsibilities and family support.

Taking the Next Step

A skin cancer diagnosis deserves careful attention, but it does not always mean a long or complicated treatment journey. Many skin cancers are highly treatable when addressed early, and even complex cases can often be managed with a structured plan and the right combination of specialists. The first step is to confirm the diagnosis, understand the stage and review all suitable treatment options.

If you have a suspicious lesion, a recent biopsy result, a melanoma diagnosis, a recurrent skin cancer or a recommendation for surgery, radiotherapy or systemic therapy, you may request a consultation or second opinion with Acibadem. Sharing your pathology report, photographs, imaging and prior treatment details can help the medical team guide you on the most appropriate next steps before you travel.

This information is general and is not a substitute for professional medical advice. Diagnosis and treatment decisions should be made with a qualified physician after an individual medical evaluation.